Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 4/2016

01.04.2016 | Original Article – Cancer Research

Assessment of the clinical relevance of 17q25.3 copy number and three-dimensional telomere organization in non-small lung cancer patients

verfasst von: Patrapim Sunpaweravong, Kelsie L. Thu, Wan L. Lam, Sabine Mai

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To identify potential biomarkers that may provide new therapeutic targets or prognostic indicators for non-small cell lung cancer (NSCLC), we investigated the three-dimensional (3D) organization of telomeres and cytoband 17q25.3 copy number in NSCLC tissues.

Methods

NSCLC paraffin-embedded tissue specimens from 18 patients were assessed for 3D telomere organization by 3D nuclear telomere imaging followed by quantitative analysis. Patients were stratified by smoking, histology, and EGFR status. Cytoband 17q25.3 was examined by fluorescent in situ hybridization. Data from comparative genomic hybridization and/or single nucleotide polymorphism arrays for cytoband 17q25.3 were obtained and correlated with Q-FISH and 3D telomere results.

Results

3D telomeric profiling demonstrated that the smokers, EGFR-negative, and squamous cell carcinoma subgroups tended to have higher numbers of lower-intensity telomeres, indicative of shorter telomeres, as well as higher numbers of telomeric aggregations compared to non-smokers, EGFR-positive, and adenocarcinomas, respectively. Gains of cytoband 17q25.3 in conjunction with an increase in the control region 17p11.2 were observed in 7 of 18 (38.9 %) patients, reflecting a gain of chromosome 17. Clonal gains of cytoband 17q25.3 were observed in 11 of 18 (61 %) patients, highlighting a potential biological significance for the genes in this region in NSCLC tumourigenesis.

Conclusions

The 3D telomere profiles may differentiate NSCLC patients with different histologies, EGFR, and smoking statuses, rendering them a potential biomarker for distinguishing these clinically relevant histological and molecular subtypes of lung cancer. Highly frequent clonal gain of cytoband 17q25.3 was also demonstrated, suggesting an important biological role for the genes in this region.
Literatur
Zurück zum Zitat Bermudo R, Abia D, Ferrer B et al (2008) Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancer. BMC Cancer 8:315–326CrossRefPubMedPubMedCentral Bermudo R, Abia D, Ferrer B et al (2008) Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancer. BMC Cancer 8:315–326CrossRefPubMedPubMedCentral
Zurück zum Zitat Choi JS, Zheng LT, Ha E et al (2006) Comparative genomic hybridization array analysis and real-time PCR reveals genomic copy number alteration for lung adenocarcinomas. Lung 184:355–362CrossRefPubMed Choi JS, Zheng LT, Ha E et al (2006) Comparative genomic hybridization array analysis and real-time PCR reveals genomic copy number alteration for lung adenocarcinomas. Lung 184:355–362CrossRefPubMed
Zurück zum Zitat Gadji M, Fortin D, Tsanaclis A et al (2010) Three-dimensional nuclear telomere architecture is associated with differential time to progression and overall survival in glioblastoma patients. Neoplasia 12:183–191CrossRefPubMedPubMedCentral Gadji M, Fortin D, Tsanaclis A et al (2010) Three-dimensional nuclear telomere architecture is associated with differential time to progression and overall survival in glioblastoma patients. Neoplasia 12:183–191CrossRefPubMedPubMedCentral
Zurück zum Zitat Gadji M, Adebayo Awe J, Rodrigues P et al (2012) Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups. Clin Cancer Res 18:3293–3304CrossRefPubMed Gadji M, Adebayo Awe J, Rodrigues P et al (2012) Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups. Clin Cancer Res 18:3293–3304CrossRefPubMed
Zurück zum Zitat Goeze A, Schlüns K, Wolf G et al (2002) Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J Pathol 196:8–16CrossRefPubMed Goeze A, Schlüns K, Wolf G et al (2002) Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J Pathol 196:8–16CrossRefPubMed
Zurück zum Zitat Helou K, Walentinsson A, Levan G et al (2001) Between rat and mouse zoo-FISH reveals 49 chromosomal segments that have been conserved in evolution. Mamm Genome 12:765–771CrossRefPubMed Helou K, Walentinsson A, Levan G et al (2001) Between rat and mouse zoo-FISH reveals 49 chromosomal segments that have been conserved in evolution. Mamm Genome 12:765–771CrossRefPubMed
Zurück zum Zitat Kim ES, Ye Y, Vaporciyan AA et al (2015) Telomere length and recurrence risk after curative resection in patients with early-stage non–small-cell lung cancer: a prospective cohort study. J Thorac Oncol 10:302–308CrossRefPubMedPubMedCentral Kim ES, Ye Y, Vaporciyan AA et al (2015) Telomere length and recurrence risk after curative resection in patients with early-stage non–small-cell lung cancer: a prospective cohort study. J Thorac Oncol 10:302–308CrossRefPubMedPubMedCentral
Zurück zum Zitat Mai S, Garini Y (2006) The significance of telomeric aggregates in the interphase nuclei of tumor cells. J Cell Biochem 97:904–915CrossRefPubMed Mai S, Garini Y (2006) The significance of telomeric aggregates in the interphase nuclei of tumor cells. J Cell Biochem 97:904–915CrossRefPubMed
Zurück zum Zitat Prescott J, Wentzensen IM, Savage SA et al (2012) Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. Mutat Res 730:75–84CrossRefPubMedPubMedCentral Prescott J, Wentzensen IM, Savage SA et al (2012) Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. Mutat Res 730:75–84CrossRefPubMedPubMedCentral
Zurück zum Zitat Seow WJ, Cawthon RM, Purdue MP et al (2014) Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts. Cancer Res 74:4090–4098CrossRefPubMedPubMedCentral Seow WJ, Cawthon RM, Purdue MP et al (2014) Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts. Cancer Res 74:4090–4098CrossRefPubMedPubMedCentral
Zurück zum Zitat Sy SM, Wong N, Mok TS et al (2003) Genetic alterations of lung adenocarcinoma in relation to smoking and ethnicity. Lung Cancer 41:91–99CrossRefPubMed Sy SM, Wong N, Mok TS et al (2003) Genetic alterations of lung adenocarcinoma in relation to smoking and ethnicity. Lung Cancer 41:91–99CrossRefPubMed
Zurück zum Zitat Vermolen BJ, Garini Y, Mai S et al (2005) Characterizing the three-dimensional organization of telomeres. Cytometry A 67:144–150. Erratum in: (2007) Cytometry A 71:345 Vermolen BJ, Garini Y, Mai S et al (2005) Characterizing the three-dimensional organization of telomeres. Cytometry A 67:144–150. Erratum in: (2007) Cytometry A 71:345
Zurück zum Zitat Wiener FL, Schmälter AK, Mowat MR et al (2010) Duplication of subcytoband 11E2 of chromosome 11 is regularly associated with accelerated tumor development in v-abl/myc-induced mouse plasmacytomas. Genes Cancer 1:847–858CrossRefPubMedPubMedCentral Wiener FL, Schmälter AK, Mowat MR et al (2010) Duplication of subcytoband 11E2 of chromosome 11 is regularly associated with accelerated tumor development in v-abl/myc-induced mouse plasmacytomas. Genes Cancer 1:847–858CrossRefPubMedPubMedCentral
Metadaten
Titel
Assessment of the clinical relevance of 17q25.3 copy number and three-dimensional telomere organization in non-small lung cancer patients
verfasst von
Patrapim Sunpaweravong
Kelsie L. Thu
Wan L. Lam
Sabine Mai
Publikationsdatum
01.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 4/2016
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-015-2080-5

Weitere Artikel der Ausgabe 4/2016

Journal of Cancer Research and Clinical Oncology 4/2016 Zur Ausgabe

Review – Cancer Research

PLCε signaling in cancer

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.